DR-TB
Daily Round-up | J&J anti-TB drug loses patent extension bid in India & other stories
In today’s episode, we look at a verdict from India that will bring relief to patients of drug-resistant TB, the dismissal of workers from a factory in Myanmar and the ban on transgender athletes from participating in women’s events
Patent Opposition Filed For Johnson And Johnson’s TB Medicine
Nandita Venkatesan and her co-petitioner from South Africa, Phumeza Tisile, are challenging a further extension of the patent that Johnson & Johnson has applied for the salt form of the drug, bedaquline that could be of vital importance in treating drug-resistant TB
- Student movement for Palestine stands defiant in face of police repression
- Tiktok ban signed into law
- Mass graves discovered at Nasser Hospital as Israel prepares for Rafah ground invasion
- Columbia University threatens to deploy National Guard to evict Gaza solidarity encampment
- Digital Health in Brazil: imperial threat or promise of sovereignty?
